[Myasthenia gravis induced by atezolizumab].
作者信息
García-García J, Díaz-Maroto I, González-Villar E, Martínez-Martín A
机构信息
Complejo Hospitalario Universitario de Albacete, Albacete, España.
出版信息
Rev Neurol. 2022 May 16;74(10):343-344. doi: 10.33588/rn.7410.2021264.
Abstract
摘要
相似文献
1
[Myasthenia gravis induced by atezolizumab].阿替利珠单抗诱发的重症肌无力
Rev Neurol. 2022 May 16;74(10):343-344. doi: 10.33588/rn.7410.2021264.
2
Rituximab in the treatment of pembrolizumab-induced myasthenia gravis.利妥昔单抗治疗帕博利珠单抗诱导的重症肌无力
Eur J Cancer. 2018 Oct;102:49-51. doi: 10.1016/j.ejca.2018.07.125. Epub 2018 Aug 20.
3
Pembrolizumab-induced Myasthenia Gravis Relapse after Immunosuppressive Therapy.帕博利珠单抗诱导免疫抑制治疗后重症肌无力复发。
Intern Med. 2022 Nov 1;61(21):3281-3285. doi: 10.2169/internalmedicine.8554-21. Epub 2022 Apr 9.
4
[Myasthenia gravis induced by inmuno checkpoints inhibitors: first case report secondary to avelumab therapy and review of published cases].[免疫检查点抑制剂诱发的重症肌无力：首例继发于阿维鲁单抗治疗的病例报告及已发表病例综述]
Rev Neurol. 2019 Apr 16;68(8):333-338. doi: 10.33588/rn.6808.2018497.
5
Liver Cancer with Overlapping Myasthenia Gravis, Myocarditis, Seronegative Autoimmune Autonomic Ganglionopathy, and Myositis Symptoms Induced by Atezolizumab.阿替利珠单抗诱导的伴有重叠性重症肌无力、心肌炎、血清阴性自身免疫性自主神经节神经病和肌炎症状的肝癌。
Intern Med. 2024 Aug 1;63(15):2193-2198. doi: 10.2169/internalmedicine.1801-23. Epub 2024 Jan 2.
6
Myasthenia gravis exacerbation associated with pembrolizumab.与帕博利珠单抗相关的重症肌无力加重。
Muscle Nerve. 2016 Sep;54(3):506-7. doi: 10.1002/mus.25055. Epub 2016 Mar 12.
7
Pembrolizumab-associated ocular myasthenia gravis.帕博利珠单抗相关的眼肌型重症肌无力
Clin Exp Ophthalmol. 2019 Aug;47(6):796-798. doi: 10.1111/ceo.13499. Epub 2019 Apr 1.
8
Myasthenia gravis induced by pembrolizumab in a patient with metastatic Merkel cell carcinoma.帕博利珠单抗诱发的转移性默克尔细胞癌患者的重症肌无力。
Ann Dermatol Venereol. 2022 Jun;149(2):142-145. doi: 10.1016/j.annder.2022.01.002. Epub 2022 Feb 18.
9
Pembrolizumab-induced myasthenia gravis: A fatal case report.帕博利珠单抗诱发的重症肌无力：一例死亡病例报告。
J Oncol Pharm Pract. 2018 Mar;24(2):146-149. doi: 10.1177/1078155216687389. Epub 2017 Feb 1.
10
Refractory myasthenia gravis exacerbation triggered By pembrolizumab.派姆单抗引发的难治性重症肌无力加重
Muscle Nerve. 2018 Apr;57(4):E120-E121. doi: 10.1002/mus.26021. Epub 2017 Dec 7.
引用本文的文献
1
Exploring the role of immune checkpoint inhibitors in the etiology of myasthenia gravis and Lambert-Eaton myasthenic syndrome: A systematic review.探索免疫检查点抑制剂在重症肌无力和兰伯特-伊顿肌无力综合征病因学中的作用：一项系统评价。
Front Neurol. 2023 Jan 9;13:1004810. doi: 10.3389/fneur.2022.1004810. eCollection 2022.
本文引用的文献
1
Neurologic Adverse Events of Immune Checkpoint Inhibitors: A Systematic Review.免疫检查点抑制剂的神经不良反应：系统评价。
Neurology. 2021 Apr 20;96(16):754-766. doi: 10.1212/WNL.0000000000011795. Epub 2021 Mar 2.
2
International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update.国际重症肌无力管理共识指南：2020 年更新版。
Neurology. 2021 Jan 19;96(3):114-122. doi: 10.1212/WNL.0000000000011124. Epub 2020 Nov 3.
3
Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature.免疫检查点抑制剂相关重症肌无力：单中心经验和文献系统评价。
J Immunother Cancer. 2019 Nov 21;7(1):319. doi: 10.1186/s40425-019-0774-y.
4
De Novo Myasthenia Gravis Induced by Atezolizumab in a Patient with Urothelial Carcinoma.阿替利珠单抗诱发的尿路上皮癌患者新发重症肌无力
Cureus. 2019 Jun 25;11(6):e5002. doi: 10.7759/cureus.5002.
5
Immune checkpoint inhibitors-induced neuromuscular toxicity: From pathogenesis to treatment.免疫检查点抑制剂诱导的神经肌肉毒性：从发病机制到治疗。
J Peripher Nerv Syst. 2019 Oct;24 Suppl 2:S74-S85. doi: 10.1111/jns.12339.
6
Cancer immunotherapy using checkpoint blockade.使用免疫检查点阻断的癌症免疫疗法。
Science. 2018 Mar 23;359(6382):1350-1355. doi: 10.1126/science.aar4060. Epub 2018 Mar 22.
7
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.与免疫检查点阻断相关的免疫相关不良事件。
N Engl J Med. 2018 Jan 11;378(2):158-168. doi: 10.1056/NEJMra1703481.
8
Neurological toxicities associated with immune-checkpoint inhibitors.与免疫检查点抑制剂相关的神经毒性。
Curr Opin Neurol. 2017 Dec;30(6):659-668. doi: 10.1097/WCO.0000000000000503.
9
Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature.与免疫检查点抑制剂相关的神经不良事件：文献复习。
Eur J Cancer. 2017 Mar;73:1-8. doi: 10.1016/j.ejca.2016.12.001. Epub 2017 Jan 5.
Zotero 插件